BRPI0607358A2 - uso de inibidores de tirosina quinase para o tratamento da rinossinusite crÈnica, bem como medicamento - Google Patents

uso de inibidores de tirosina quinase para o tratamento da rinossinusite crÈnica, bem como medicamento

Info

Publication number
BRPI0607358A2
BRPI0607358A2 BRPI0607358-1A BRPI0607358A BRPI0607358A2 BR PI0607358 A2 BRPI0607358 A2 BR PI0607358A2 BR PI0607358 A BRPI0607358 A BR PI0607358A BR PI0607358 A2 BRPI0607358 A2 BR PI0607358A2
Authority
BR
Brazil
Prior art keywords
treatment
kinase inhibitors
well
chronic rhinosinusitis
tyrosine kinase
Prior art date
Application number
BRPI0607358-1A
Other languages
English (en)
Inventor
Bernd Disse
Gerald Pohl
Birgit Jung
Original Assignee
Boeringer Ingelheim Internat Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36228798&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0607358(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE102005005505A external-priority patent/DE102005005505A1/de
Priority claimed from DE102005036216A external-priority patent/DE102005036216A1/de
Application filed by Boeringer Ingelheim Internat Gmbh filed Critical Boeringer Ingelheim Internat Gmbh
Publication of BRPI0607358A2 publication Critical patent/BRPI0607358A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Abstract

USO DE INIBIDORES DE TIROSINA QUINASE PARA O TRATAMENTO DA RINOSSINUSITE CRÈNICA, BEM COMO MEDICAMENTO. A presente invenção refere-se ao uso de selecionados inibidores de EGFR quinase, particularmente de selecionadas quinazolinas, quinolinas e pirimido-pirimidinas, para o tratamento de poliposes nasais e da rinossinusite crónica.
BRPI0607358-1A 2005-02-04 2006-01-16 uso de inibidores de tirosina quinase para o tratamento da rinossinusite crÈnica, bem como medicamento BRPI0607358A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005005505A DE102005005505A1 (de) 2005-02-04 2005-02-04 Verwendung von Tyrosinkinase-Inhibitoren zur Behandlung der chronischen Rhinosinusitis
DE102005036216A DE102005036216A1 (de) 2005-08-02 2005-08-02 Verwendung von Tyrosinkinase-Inhibitoren zur Behandlung der chronischen Rhinosinusitis
PCT/EP2006/050215 WO2006082129A1 (de) 2005-02-04 2006-01-16 Verwendung von tyrosinkinase-inhibitoren zur behandlung der chronischen rhinosinusitis

Publications (1)

Publication Number Publication Date
BRPI0607358A2 true BRPI0607358A2 (pt) 2009-09-01

Family

ID=36228798

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0607358-1A BRPI0607358A2 (pt) 2005-02-04 2006-01-16 uso de inibidores de tirosina quinase para o tratamento da rinossinusite crÈnica, bem como medicamento

Country Status (14)

Country Link
US (1) US20060178364A1 (pt)
EP (1) EP1845992A1 (pt)
JP (1) JP2009523700A (pt)
KR (1) KR20070108889A (pt)
AR (1) AR055029A1 (pt)
AU (1) AU2006210175A1 (pt)
BR (1) BRPI0607358A2 (pt)
CA (1) CA2601740A1 (pt)
EA (1) EA200701619A1 (pt)
IL (1) IL184997A0 (pt)
MX (1) MX2007009265A (pt)
NO (1) NO20073097L (pt)
TW (1) TW200638937A (pt)
WO (1) WO2006082129A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110104166A1 (en) 2008-01-18 2011-05-05 Stankovic Konstantina M Methods and Compositions for Treating Polyps
US8629153B2 (en) 2008-09-03 2014-01-14 Boehringer Ingelheim International Gmbh Use of quinazoline derivatives for the treatment of viral diseases
WO2010054285A2 (en) 2008-11-10 2010-05-14 National Health Research Institutes Fused bicyclic and tricyclic pyrimidine compounds as tyrosine kinase inhibitors
CN104844580B (zh) * 2015-04-17 2017-10-20 中国药科大学 嘧啶类化合物、其制备方法及医药用途
US20170007704A1 (en) * 2015-07-09 2017-01-12 David Ram Carrier and pharmaceutical compositions for intrasinal delivery and uses thereof
CN110291104B (zh) 2016-11-17 2023-11-03 得克萨斯州大学系统董事会 具有针对携带egfr或her2外显子20突变之癌细胞的抗肿瘤活性的化合物
RU2646806C1 (ru) * 2017-05-05 2018-03-07 Дмитрий Александрович Щербаков Способ лечения хронического полипозного риносинусита
KR20220057993A (ko) 2020-10-30 2022-05-09 오창민 코막힘, 콧물 등 알레르기 비염을 포함한 부비동 질환의 증상 개선을 위한 식품 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10042062A1 (de) * 2000-08-26 2002-03-07 Boehringer Ingelheim Pharma Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Hertellung
DE10204462A1 (de) * 2002-02-05 2003-08-07 Boehringer Ingelheim Pharma Verwendung von Tyrosinkinase-Inhibitoren zur Behandlung inflammatorischer Prozesse
CN1642552B (zh) * 2002-03-30 2010-05-12 贝林格尔英格海姆法玛两合公司 作为酪氨酸激酶抑制剂的4-(n-苯氨基)-喹唑啉/喹啉
DE10334226A1 (de) * 2003-07-28 2005-02-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Tyrosinkinase-Inhibitoren zur Behandlung inflammatorischer Prozesse
DE10350717A1 (de) * 2003-10-30 2005-06-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Tyrosinkinase-Inhibitoren zur Behandlung inflammatorischer Prozesse

Also Published As

Publication number Publication date
EA200701619A1 (ru) 2008-02-28
TW200638937A (en) 2006-11-16
JP2009523700A (ja) 2009-06-25
CA2601740A1 (en) 2006-08-10
WO2006082129A1 (de) 2006-08-10
MX2007009265A (es) 2007-09-07
AU2006210175A1 (en) 2006-08-10
NO20073097L (no) 2007-07-12
US20060178364A1 (en) 2006-08-10
AR055029A1 (es) 2007-08-01
IL184997A0 (en) 2007-12-03
KR20070108889A (ko) 2007-11-13
EP1845992A1 (de) 2007-10-24

Similar Documents

Publication Publication Date Title
BRPI0607358A2 (pt) uso de inibidores de tirosina quinase para o tratamento da rinossinusite crÈnica, bem como medicamento
CY2017012I2 (el) Αναστολεις κινασης τυροσινης bruton
EA200870410A1 (ru) Антагонисты киназы
BRPI0816064A2 (pt) Inibidores da atividade de proteína tirosina cinase.
ATE474835T1 (de) Als inhibitoren von proteinkinasen geeignete aminopyrimidine
DK1848414T3 (da) Fremgangsmåde til behandling af gefitinib-resistent cancer
EP1945631B8 (en) 4- (3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer
BRPI0812893A2 (pt) Derivados de quinoxalina como inibidores da atividade de tirosina quinase de janus quinases
BRPI0807897A2 (pt) Derivados de pirimidina-2,4-diamina e seus usos como inibidores de jak2 quinase.
ATE395346T1 (de) Chinazolinderivate als tyrosinkinaseinhibitoren
BR112015021458A8 (pt) Processos e intermediários para preparar um inibidor de jak
DE602007008529D1 (de) Als pi-3-kinaseinhibitoren verwendete pyrimidinderivate
TW200628452A (en) Substituted 2-anilinopyrimidines as cell-cycle-kinase or receptor-tyrosine-kinase inhibitors, their production and use as pharmaceutical agents
WO2007109783A3 (en) Substituted pyrimidine kinase inhibitors
DE602007013295D1 (de) Substituierte isochinoline und ihre verwendung als rho-kinase-inhibitoren
EA201391470A1 (ru) Замещенные соли 2,3-дигидроимидазо[1,2-c]хиназолина
ATE526328T1 (de) Als inhibitoren von proteinkinasen geeignete aminopyrimidine
NZ580671A (en) Pyrimidine derivatives
WO2009006389A8 (en) Pyrimidine derivatives useful as raf kinase inhibitors
WO2010054285A3 (en) Fused bicyclic and tricyclic pyrimidine compounds as tyrosine kinase inhibitors
BR112012007300A2 (pt) derivador de pirimidina como inibidores proteína tirosina cinase 2
ATE553104T1 (de) Substituierte 1h-benzimidazol-4-carboxamide als potente parp-hemmer
WO2007081630A3 (en) Substituted pyrimidinyl kinase inhibitors
PL1854789T3 (pl) Pochodna chinazoliny mająca aktywność hamowania kinazy tyrozynowej
WO2007129226A3 (en) Use of syk tyrosine kinase inhibitors for the treatment of cell proliferative disorders

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2161 DE 05/06/2012.